Epstein-Barr virus drug
Evidence from:
primary |
all sources
No related entities found.
Mentioned in (12)
Papers in which this entity is mentioned.
- Epigenetic analysis of cell-free DNA by fragmentomic profiling. (2022)
- Feasibility of whole genome and transcriptome profiling in pediatric and young adult cancers. (2022)
- SVXplorer: Three-tier approach to identification of structural variants via sequential recombination of discordant cluster signatures. (2020)
- Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. (2019)
- Super-enhancers: critical roles and therapeutic targets in hematologic malignancies. (2019)
- The impact of structural variation on human gene expression. (2017)
- DNA methylation contributes to natural human variation. (2013)
- A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. (2013)
- The Genotype-Tissue Expression (GTEx) project. (2013)
- Zebrafish models of human liver development and disease. (2013)
- Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort. (2010)
- Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. (2005)
Merged raw entities (1)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| epstein-barr virus | drug | 12 | 14 |